These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25232223)

  • 1. LRP5 polymorphism-A potential predictor of the clinical outcome in advanced gastric cancer patients treated with EOF regimen.
    Liu X; Huang MZ; Chen ZY; Zhao XY; Wang CC; Peng W; Yin JL; Li J; Zhu XD
    Chin J Cancer Res; 2014 Aug; 26(4):478-85. PubMed ID: 25232223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of apatinib and VEGFR2-906T>C polymorphism on clinical outcomes of advanced non-small cell lung cancer patients].
    Zhao RH; Zhou YN; Li H; Li R; Zhang WJ; Zong H
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):105-110. PubMed ID: 30669747
    [No Abstract]   [Full Text] [Related]  

  • 3. Low density lipoprotein receptor-related protein 5 gene polymorphisms and osteoporosis in Thai menopausal women.
    Kitjaroentham A; Hananantachai H; Phonrat B; Preutthipan S; Tungtrongchitr R
    J Negat Results Biomed; 2016 Sep; 15(1):16. PubMed ID: 27582019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer.
    Zhuo YJ; Shi Y; Wu T
    Oncol Lett; 2019 Nov; 18(5):4629-4638. PubMed ID: 31611971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy.
    Feng W; Liu X; Zhao X; Huang M; Guo W; Yin J; Chen Z; Zhu X
    Oncol Lett; 2018 Oct; 16(4):4489-4497. PubMed ID: 30214584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of polymorphisms of VEGFR2 on clinical outcomes and safety of advanced non-small-cell lung cancer treated by first line Bevacizumab plus chemotherapy regimens].
    Fan HJ; Yuan J; Wu JJ; Jia YX; Ma YH; Li XY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):99-104. PubMed ID: 30669746
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.
    Geng N; Ding CM; Liu ZK; Song S; Hu WX
    Int J Clin Oncol; 2021 Apr; 26(4):670-683. PubMed ID: 33392882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The impact of genetic variation of KDR on clinical outcomes of advanced colorectal cancer patients treated by first line bevacizumab based regimens].
    Wang HX; Mei X; Gong TX; Han N; Liu P; Wang J; Zhang ZM
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2737-2742. PubMed ID: 30220171
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy.
    Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K
    Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.
    Tang W; Liu X; Qiu L; Zhao X; Huang M; Yin J; Li J; Guo W; Zhu X; Chen Z
    Oncol Lett; 2018 Jan; 15(1):1334-1342. PubMed ID: 29399184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of LRP5 gene polymorphism with type 2 diabetes mellitus and osteoporosis in postmenopausal women.
    Xuan M; Wang Y; Wang W; Yang J; Li Y; Zhang X
    Int J Clin Exp Med; 2014; 7(1):247-54. PubMed ID: 24482712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 13. VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.
    Beuselinck B; Karadimou A; Lambrechts D; Claes B; Wolter P; Couchy G; Berkers J; van Poppel H; Paridaens R; Schöffski P; Méjean A; Verkarre V; Lerut E; Joly F; Lebret T; Gravis G; Deplanque G; Descazeaud A; Leclercq NR; Molinié V; Patard JJ; Teghom C; Elaidi R; Zucman-Rossi J; Oudard S
    Acta Oncol; 2014 Jan; 53(1):103-12. PubMed ID: 23421954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
    Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
    PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy.
    Shitara K; Matsuo K; Muro K; Doi T; Ohtsu A
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1383-9. PubMed ID: 23708301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
    Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
    Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common polymorphism in the LRP5 gene may increase the risk of bone fracture and osteoporosis.
    Xu GY; Qiu Y; Mao HJ
    Biomed Res Int; 2014; 2014():290531. PubMed ID: 25580429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
    Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
    Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
    Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
    Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.